MoneyWorks4Me

Syschem (India) - Quaterly Results

09 Feb 2024 Evaluate
A decent increase of about 48.80% in the sales to Rs. 515.11 millions was observed for the quarter ended December 2023. The sales figure stood at Rs. 346.18 millions during the year-ago period.The company reported a drastic decline of -88.87% in the quarter ended December 2023 to Rs. 2.31  millions from Rs. 20.75 millions  .A decline of 10.82 millions was observed in the OP in the quarter ended December 2023 from 28.45 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 515.11 346.18 48.80 1454.75 734.67 98.01 1303.77 656.33 98.65
Other Income 0.12 0.05 140.00 0.19 1.90 -90.00 2.48 1.26 96.83
PBIDT 10.82 28.45 -61.97 53.86 63.18 -14.75 88.96 6.93 1183.69
Interest 1.07 0.56 91.07 2.42 0.84 188.10 0.42 2.84 -85.21
PBDT 9.75 27.89 -65.04 51.44 62.34 -17.48 88.54 4.09 2064.79
Depreciation 7.44 7.14 4.20 21.19 21.10 0.43 27.03 25.81 4.73
PBT 2.31 20.75 -88.87 30.25 41.24 -26.65 61.51 -21.72 -383.20
TAX 0.00 0.00 0.00 0.00 0.00 0.00 16.38 -4.66 -451.50
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 16.38 -4.66 -451.50
PAT 2.31 20.75 -88.87 30.25 41.24 -26.65 45.13 -17.06 -364.54
Equity 398.63 318.90 25.00 398.63 318.90 25.00 318.90 232.90 36.93
PBIDTM(%) 2.10 8.22 -74.44 3.70 8.60 -56.95 6.82 1.06 546.21
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..